Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clemastine on PACAP38-induced Migraine
NCT02364453Completed
- Start
- Feb 2015
- Primary completion
- Apr 2016
- Countries
- 1
01
Overview
Randomised, double-blind trial of clemastine in migraine without aura. Primary endpoint: Development of migraine in migraine patients at 12 hours. Started Feb 2015; status: completed.
02
Drugs
clemastine
03
Conditions
migraine without aura
Beyond the preview
Go deeper on NCT02364453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02364453.